Why collaborate with Medical Flowers Developments?

Collaborations

Medical Flowers Developments is built upon the experience of its team and a network of leading pharmaceutical and industrial partners, enabling cannabinoids to be addressed as genuine pharmaceutical programs, from pharmaceutical formulation to clinical readiness, in collaboration with the program sponsor.

Pharmaceutical formulation expertise with preclinical validation

MFD has demonstrated its capability to transform botanical-derived cannabinoids into a controlled pharmaceutical dosage form, with reproducible dosing and consistent performance. Pharmaceutical formulation development constitutes the core of the project and integrates formulation design, release control, cannabinoid profile standardization and the generation of preclinical data, establishing a solid foundation for the transition to clinical development.

Pharmaceutical partner for the transition to clinical development

We act as a technical partner to bring cannabinoid programs from preclinical stages toward clinical development, providing the pharmaceutical dosage form, formulation know-how and a solid CMC foundation. Our approach prioritizes GLP preclinical data, GMP-ready development and early alignment with regulatory expectations from authorities such as the EMA and the AEMPS, enabling the sponsor to lead the clinical strategy with a medicinal product prepared to advance.

Industrial scalability integrated from the design stage

The pharmaceutical dosage form is developed from early stages with industrial scalability criteria, incorporating specifications, analytical methods, stability studies and controls oriented toward future manufacturing under Good Manufacturing Practices (GMP). The full-spectrum approach is addressed from a pharmaceutical perspective, prioritizing definition, control and reproducibility to ensure batch-to-batch consistency and industrial feasibility, in collaboration with a network of specialized industrial and scientific partners.

contact

Professional contact

Medical Flowers Developments collaborates with pharmaceutical and biotech companies interested in cannabinoid clinical trials. The company maintains an open approach to professional discussions focused on development, innovation, and investment in regulated projects.